An unusual presentation of Stewart-Treves syndrome on the lower extremity  by Whitney, Kristen et al.
CASE REPORTAn unusual presentation of Stewart-Treves
syndrome on the lower extremity
Kristen Whitney, DO,a Brian Schapiro, MD,b and Ann Ammond LaFond, MDa
Ann Arbor, MichiganFrom
St
Fund
Confl
This c
wh
Fe
Ap
HoKey words: chronic lymphedema; cutaneous angiosarcoma; lymphangiosarcoma; mastectomy; peripheral
edema; Stewart-Treves syndrome.INTRODUCTION
Cutaneous angiosarcoma is a rare and aggressive
malignant tumor derived from endothelial cells,
which can develop de novo, in irradiated skin, or
in areas of chronic lymphedema. Stewart-Treves
syndrome describes the association of cutaneous
angiosarcoma arising in the setting of lymphedema.
This syndrome was first reported in 1948 by Drs Fred
Stewart and Norman Treves, who noted 6 cases of
lymphangiosarcoma that developed several years
after a Halstead radical mastectomy.1
Currently there are few reports in the literature of
Stewart-Treves syndrome occurring after primary or
secondary causes of chronic lymphedema not attrib-
utable to malignancy.2 Our case is an extremely rare
subtype of angiosarcoma arising in a lymphedema-
tous lower limb with no prior malignancy or radia-
tion history.
CASE REPORT
A 94-year-old African-American woman was
admitted for cellulitis of the right lower extremity and
a 3-month history of painful and bleeding cutaneous
lesions in the same area. The lesions developed rapidly
and spreadproximally. Therewas nohistory of trauma,
malignancy, pelvic surgery, long-standing infection, or
thrombosis of the lower extremities. The patient’s
chronic bilateral lower extremity lymphedema ap-
peared at age 34, shortly after the birth of her son, but
shedeniedany significant birth trauma. Shealsodenied
a family history of lymphedema. Significant medical
history included diabetes mellitus, chronic kidney
disease, and chronic venous stasis with ulcerations.the Departments of Dermatologya and Dermatopathology,b
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spital-Ann Arbor.Physical examination found an ulcerated plaque
with jaggedborders, studdedwithmultiple firmblack
nodules above the right medial malleolus. Smaller
skin-colored to black nodules and a few bullae were
dispersed around the lesion and extended up the
proximal right lower leg (Fig 1). Diffuse nonpitting
edema and hyperpigmented macules and patches
were present on the bilateral lower extremities. No
popliteal or inguinal lymphadenopathies were
noted. Our differential diagnosis included acroan-
giodermatitis, Kaposi’s sarcoma, squamous cell car-
cinoma, melanoma, and angiosarcoma.
Two punch biopsies were performed at the edge
of the tumor, which found an inflamed scale/crust
with underlying epidermal hyperplasia and
prominent ectasia of the superficial vasculature.
In the mid to deep reticular dermis there were
poorly formed vessels lined by pleomorphic and
hyperchromatic endothelial cells (Figs 2 and 3).
Occasional mitotic figures were noted and the
vessels dissected between the dermal collagen
bundles. The atypical endothelial cells were posi-
tive for CD31 and negative with pan cytokeratin
stains. Based on the clinical and pathologic
findings, a diagnosis of cutaneous angiosarcoma
was made, which had arisen within an area of
chronic lymphedema of the lower extremity.
Further workup included computed tomography
scans of the chest, abdomen, and pelvis, which were
unremarkable. The patient declined surgical inter-
vention and chemotherapy because of her age and
medical comorbities. She did receive palliative radi-
ation treatments.Correspondence to: Kristen Whitney, DO, 607 Washington Road,
Lower Level, Pittsburgh, PA 15228. E-mail: kristende@pcom.edu.
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Fig 1. Angiosarcoma. Ulcerated plaque on the right
medial lower extremity studded with multiple firm black
nodules.
Fig 2. High-power view of the reticular dermis shows
interanastomosing vascular channels dissecting through
the dermal collagen.
Fig 3. Numerous hyperchromatic and pleomorphic endo-
thelial cells at the dermal-subcutaneous junction.
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Cutaneous angiosarcoma is a destructive and
often fatal vascular tumor. The tumor can occur de
novo or secondary to well-documented risk factors,
which include radiation exposure and chronic lym-
phedema. Stewart-Treves syndrome is defined by
the development of angiosarcoma in the presence of
chronic lymphedema. Although originally describedin patients after a radical mastectomy, this syndrome
can occur in the setting of congenital or hereditary
lymphatic malformations (ie, Turner’s syndrome,
Noonan’s syndrome, Milroy’s disease, lymphedema
praecox, lymphedema tarda), chronic infections,
chronic venous stasis, morbid obesity, malignant
obstruction, and surgical procedures that disrupt
lymphatic flow.3,4 Our patient had lymphedematous
limbs for approximately 60 years until the diagnosis
of angiosarcoma. The underlying etiology of her
lymphedema remains unknown.
Clinically, de novo lesions of angiosarcoma
appear as enlarging and persistent bruiselike lesions
often on the head and neck of elderly patients.
Angiosarcoma occurring in a background of radia-
tion dermatitis or chronic lymphedema typically
presents with multicentric red-purple papules and
nodules. Angiosarcoma can be easily missed at initial
presentation for more common diagnoses such as
cellulitis, trauma or ecchymoses in de novo lesions
and Kaposi’s sarcoma, stasis dermatitis, or acroan-
giodermatitis in the papulonodular form.
The pathophysiology of Stewart-Treves syndrome
is largely unknown, but theories of immune dysre-
gulation predominate. It is believed that disruption
of lymphatic flow secondary to injury from radiation
or chronic lymphedema leads to an impairment of
the regional immune system, which can promote
atypical angiogenesis and neoplasia.5
Pathologic findings are critical in making the
diagnosis of cutaneous angiosarcoma. Tumors can
range from well-differentiated subtypes, making
distinction from benign vascular tumors and
proliferations difficult, to poorly differentiated tu-
mors in which it can be challenging to set apart from
other vascular tumors, sarcomas, melanomas, and
carcinomas.
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angiosarcoma include an infiltrative network of
sinusoidal vessels invading the dermal collagen.
Large pleomorphic and hyperchromatic cells may
form papillary projections lining the endothelial
lumen. Significant hemorrhage and blood-filled
cavities can occur. A large percentage of angiosarco-
mas stain positive for CD31 and CD34, of which,
CD31 is the more sensitive and specific of the two.
Cytokeratin stains may be positive in some epithe-
lioid angiosarcomas.6,7
Treatment is based on the general health of the
patient, tumor location, histologic subtype, and
extent of involvement. Localized and advanced
cutaneous disease are frequently treated similarly
with neoadjuvant chemotherapy followed by wide
local excision or amputation and radiation ther-
apy.6,8 Additional therapeutic options for locally
advanced disease include the use of locoregional
modalities such as isolated limb perfusion, limb
infusion, and electrochemotherapy.9 Radiation af-
fords a palliative treatment option in patients not
desiring radical therapies as seen in our case.
Despite treatment, the prognosis of cutaneous
angiosarcoma regardless of subtype remains poor.
Survival rates range from 51% at 5 years to 43% at
10 years. Patients with localized disease have a better
overall outcome with 5- and 10-year survival rates of
62% and 54%, respectively. Those with distantmetastasis had a 6.2% chance of survival at both 5
and 10 years.10
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